Analyst Faisal Khurshid of Leerink Partners maintained a Hold rating on Ironwood Pharma (IRWD – Research Report), retaining the price ...

According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research ...

Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

F&O data shows, on Friday Aarti Industries, Aurobindo Pharma and Trent saw a dip in share price alongside rise in open ...

The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Greetings, and welcome to the Achieve Life Sciences Third Quarter ...

Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...

The Pharma & Biotech market had a relatively muted month. There were a number of companies that experienced strong share ...

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in ...

I don’t foresee major policy-driven changes impacting Indian pharma exports to the US ... Will the act influence Cipla’s manufacturing strategy? The trend of manufacturing closer to the US market ...

Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...

Trump's policies can be positive for US growth but can lead to slower growth, currency volatility in other economies.